Prepare / Orlando care guide
Compare the whole bill
A headline price can leave questions unanswered. Ask for the medicine, the visit, and any later charges on the same written quote.
Ask which price you are seeing
As of September 26, 2026, these medicines had different prices depending on how you paid. A maker’s published price is called a list price; it differs from offers for people paying without insurance and amounts paid through insurance.
For an Orlando office or an online service, ask for a written total that reaches past the first month.
- Is this the medicine price or the whole care bill?
- What changes after the opening offer?
- What will later refills and visits cost?
A cash-price starting point
On September 26, 2026, the federal cash-price site listed semaglutide (Wegovy tablets) from $149 per month.
That day’s starting offer for tirzepatide (Zepbound injections) was $299 per month.
These starting offers applied to the lowest strength; other strengths cost more.
The September 26, 2026 price check found many offers with terms ending December 31, 2026.
Ask for the price of the product actually prescribed, including the later refill price. Add any other charges to your written care budget.
Word help: cash and list prices
A cash price is an offer outside insurance; a list price is what the maker publishes.
Ask what else is charged
Ask for each item to be marked as included, extra, or not part of the plan. Compare totals using the same items.
- The first health check and later visits.
- Membership fees, money paid in advance, and any agreement to keep paying for a set number of months.
- Medicine, delivery, tests, and test review.
- Later refill charges and cancellation terms.
Insurance is a separate check
For Part D, Medicare’s usual drug benefit, use only for weight loss remained excluded as of September 26, 2026.
A different use, such as diabetes, may qualify; the plan still applies its medicine list and approval process.
Ask your insurer to check the specific product for the condition you need treated.
- Is the drug on my plan’s medicine list?
- Does the plan need to agree before the prescription is filled?
- What amount would I pay under this plan?
Word help: prior authorisation
Prior authorisation means an insurer agrees to pay before the prescription is filled.
A Medicare option to ask about
GLP-1 medicines copy a hormone. This body signal is involved in blood sugar and appetite.
The Medicare GLP-1 Bridge is a limited programme for selected weight-loss medicines.
Eligible Part D members paid $50 for each monthly supply through this programme, as of September 26, 2026.
According to that check, July 1, 2026 is the programme’s start date, and December 31, 2027 is its end date.
Part D sets a yearly payment cap for medicines your plan covers. Once you reach that cap, you pay no more for those medicines that year. The Bridge’s $50 payment stays outside the cap, as of September 26, 2026.
Eligibility as of September 26, 2026 depends on age, health conditions, plan type, and earlier use of GLP-1 medicines through Part D.
A prescription and prior approval from the programme are required, as of September 26, 2026.
The Bridge excludes type 2 diabetes as of September 26, 2026. Medicine for that use goes through usual Part D.
Ask the person who writes your prescription to check whether you qualify under the programme’s rules.
Word help: GLP-1
GLP-1 is a hormone. It is a body signal involved in blood sugar and appetite; some medicines copy what it does.
Keep going
Put the product name, the total bill, and any unclear terms on your visit list.
Take a question list